Skip to content
2000
Volume 27, Issue 27
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate the expression of targets genes by binding to the 3′-untranslated regions. They play vital roles in diverse biological processes, including the development of hepatic fibrosis (HF). HF is characterized by the accumulation of extracellular matrix (ECM) and hepatic stellate cells (HSCs) are considered a major cell type for producing ECM. Alteration of the HSC phenotype plays a crucial role in the HF pathological process. MiRNAs involved in various biological process, such as differentiation, apoptosis, migration, and their relevant signaling pathways, are expressed in HSCs; however, emerging evidence indicates that numerous miRNAs are abnormally expressed in activated HSCs. In this review, we summarize the categorization of miRNAs in HF and describe the relationships among them. We also discuss miRNAs recently discovered to be related to HF, and attempt to find potential miRNAs that may serve as novel biomarkers for use in HF treatment.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612826666201023143542
2021-08-01
2025-04-09
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612826666201023143542
Loading

  • Article Type:
    Review Article
Keyword(s): biomarkers; hepatic fibrosis; hepatic stellate cells; microRNAs; Non-coding RNA; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test